During derivation of transgenic mouse strains with various TL and TL/H-2 chimeric genes, one strain, TgTle-3-1, introduced with a TL gene (Tla'-3), was found to have an abnormal thymic T cell population and to develop a high incidence of T cell lymphomas. To investigate the etiology of the thymic abnormalities and of the lymphomas, the development of lymphoid organs in transgenic mice was studied . The thymus of these mice goes through three unusual successive events : perturbation of thymic development during embryogenesis, disappearance of thymocytes between day 14 and day 21 after birth, and subsequent proliferation of large blast-like cells. These events are associated with the abolishment of T cell receptor (TCR) of lineage of the T cell differentiation, leading to preponderance of cells belonging to the TCR yS L3T4 -Lyt-2 -double negative (DN) lineage . Bone marrow transplantation and thymic graft experiments demonstrate that the abnormality resides in the bone marrow stem cells rather than in the thymic environment . The expression of TL antigen in the transgenic mice is greatly increased and TL is expressed in a wide range of T cells, including normally TL -DN cells and L3T4+ Lyt-2 -and L3T4 -Lyt-2+ single positive cells. These quantitative and qualitative abnormalities in TL expression most likely cause the abnormal T cell differentiation .
During derivation of transgenic mouse strains with various TL and TL/H-2 chimeric genes, one strain, TgTle-3-1, introduced with a TL gene (Tla'-3), was found to have an abnormal thymic T cell population and to develop a high incidence of T cell lymphomas. To investigate the etiology of the thymic abnormalities and of the lymphomas, the development of lymphoid organs in transgenic mice was studied . The thymus of these mice goes through three unusual successive events : perturbation of thymic development during embryogenesis, disappearance of thymocytes between day 14 and day 21 after birth, and subsequent proliferation of large blast-like cells. These events are associated with the abolishment of T cell receptor (TCR) of lineage of the T cell differentiation, leading to preponderance of cells belonging to the TCR yS L3T4 -Lyt-2 -double negative (DN) lineage . Bone marrow transplantation and thymic graft experiments demonstrate that the abnormality resides in the bone marrow stem cells rather than in the thymic environment . The expression of TL antigen in the transgenic mice is greatly increased and TL is expressed in a wide range of T cells, including normally TL -DN cells and L3T4+ Lyt-2 -and L3T4 -Lyt-2+ single positive cells. These quantitative and qualitative abnormalities in TL expression most likely cause the abnormal T cell differentiation .
The yS DN cells migrate into peripheral lymphoid organs and constitute nearly 50% of peripheral T cells. Immune function of the transgenic mice is severely impaired, as T cell function is defective in antibody production to sheep red blood cells, in mixed lymphocyte culture reaction to allogenic spleen cells and also in stimulation with concanavalin A . These results indicate that the yS cells are incapable of participating in these reactions.
Molecular and serological analysis of T cell lymphomas reveal that they belong to the -yb lineage, suggesting that the yb DN cells in this strain are susceptible to leukemic transformation . Based on cell surface phenotype and TCR expression of the DN thymocytes and T cell lymphomas, a map of the sequential steps involved in the differentiation of yS DN cells is proposed . Tg.Tla'-3-1 mice should be useful in defining the role of TL in normal and abnormal T cell differentiation as well as in the development of T cell lymphomas, and further they should facilitate studies on the differentiation and function of yS T cells. M ouse TL antigens belong to the family of MHC class I antigens . However, the expression of TL is distinct from other MHC class I antigens, being restricted to normal thymocytes and T cell lymphomas. Not all strains of mice express TL in the normal thymus, but even in such TLstrains an anomalous TL expression is found on T cell lym-two TL/H-2 chimeric genes (8) . Analysis of the transgene expression showed that even TL -thymocytes of OH/He provide conditions for the transcriptional activation of Tla'-3, and that Tla'-3 contains necessary elements for correct tissue-specific expression in normal thymocytes, whereas Tab and the endogenous TL genes of C3H/He lack these elements . During the course of the study, we found that one of the transgenic mouse strains, TgXla°-3-1, expresses large amounts of TL antigen in thymocytes, and has a small thymus consisting mainly of L3T4 (CD4) -Lyt-2 (CD8) -double negative (DN) cells. Furthermore, this strain develops a high incidence of lymphoid neoplasms.
The differentiation pathway of T cells bearing oiO TCR in the thymus has been extensively studied, and it has been conclusively demonstrated that the interaction between a/3 TCR and MHC antigens plays a critical role in the development of thymic T cells (for review, see references 9-12) . The maturation of cig cells in the thymus has been staged using various cell surface markers (13, 14) . The differentiation pathway of the other lineage, 76 cells, has also been vigorously investigated, and many aspects of yb cells, including function, localization of different subsets, thymic selection of certain subsets and putative ligands, have been reported (for review, see references 15-18) . yb cells, particularly those localized in epithelial structures, are speculated to function in the primary defense of the body against infection and other insults (19). However, because of the limited number of y6 cells in lymphoid organs (20) (21) (22) , analysis of their function and staging of their developmental pathway have been difficult .
In the present study, we have investigated the development of the immune system in TgXla'-3-1 mice to elucidate the role of the transgene in abnormal thymic differentiation. We found that T cell differentiation in the transgenic mice is forced to deviate to the yb lineage through at least three unusual events in the thymus and that consequently yb cells become abundant rather than a/3 cells. To delineate the function and the maturation steps involved in the differentiation of yb cells, we characterize DN thymocytes, yb T cell lymphomas and immune responses of Tg.Tla'-3-1 mice.
Materials and Methods
Mice. Derivation of the TL transgenic mouse strain, TgTla'-3-1, has been described elsewhere (8) . Briefly, a DNA fragment containing Tla'-3 isolated from an A-strain genomic library was injected into male pronuclei of fertilized eggs of C3H/He mice (TL -, Tiab) (8, 23) . The founder mouse of the TgTla'-3-1 strain contained seven copies of Tla'-3 transgenes in a single chromosomal site. The offspring ofthe founder were interbred to produce homozygous stock, which then maintained by brother-sister mating. C3H/He mice were purchased from Japan SLC Inc . (Hamamatsu, Japan), and other mice were from our breeding colony or from the National Institute of Genetics (Mishima, Japan) .
Histology. Tissues were fixed with Bouin's solution and 5 Am sections were stained with hematoxyline-eosin .
Serological Analysis. Two-color analysis of cell surface antigens was performed with a fluorescence-activated cell sorter (FACstar ; Becton Dickinson and Co., Mountain View, CA) using mAbs to TL (HD168, reference 3), L3T4 (GK1.5, reference 24), Lyt-2 (53-7,
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-y6 T Cells in TL Transgenic Mice Immune Response (A) Plaque forming cell (PFC) assay: 108 SRBC were injected intravenously into the transgenic or control mice . 1 wk later, 106 spleen cells of the immunized mice were mixed with 2 x 108 SRBC and incubated for 2 h at 37°C in agarose in the presence of guinea pig complement . The number of plaques producing IgM antibody to SRBC was counted (direct assay), and the number of plaques producing IgG and IgM antibodies was counted by addition of anti-mouse Ig (indirect assay) . DNA and RNA Blot Analysis. Probes for Southern (30) and Northern (31) blot analyses were prepared either by nick-translation (32) or by the random priming method (33) . The DNA rearrangement and RNA transcripts were analyzed with the following probes : Conditions for hybridization and washing were described previously (3, 5) .
Results
Abnormal Growth of the Thymus in Tg.Tla°-3-I Transgenic Mice. The growth of the thymus in TgTla'-3-1 mice was Changes in the weight of the lymphoid organs correlate well with those in the cell number. The weight of the thymus of transgenic mice starts from 3 .9 ± 0.3 mg at day 0, increase to 21.1 t 2.7 mg at day 14, then reduces to 13 .6 ± 2 .5 mg at day 21 and recovers to 21 .9 ± 6.2 mg at day 190 . In C3H/He mice, the weight of the thymus is 4.8 t 0.3 mg at day 0, 57.8 t 6 .9 mg at day 14, 64 .1 ± 2 .3 mg at day 21 and 36 .9 ± 4 .4 mg at day 190 . The weight of lymph nodes of transgenic mice is consistently smaller than the control ; 13 .7 ± 2.5 mg versus 24.8 ± 2.5 mg at day 14 and 69.1 ± 11.5 mg versus 92 .2 ± 16.2 mg at day 190 . Spleen weight or total body weight do not differ significantly between the transgenic and the control mice throughout the observation period .
assessed by changes in weight, cell number and histology, and was compared with that of the control C3H/He mice ( Fig. 1 and Fig. 2 ). Three unusual events were found to occur during the development of the transgenic thymus. First, at birth, the thymus of the transgenic mouse is already smaller and contains fewer cells than the control . The thymus has a thin cortex layer and the boundary of cortex and medulla is not as distinct as in control mice. Second and most strikingly, lymphoid cells abruptly disappear from the transgenic thymus between day 14 and day 21; the thymus loses 50% of its weight and 85% of its lymphoid cell population. Consequently, the thymus of 21-d and also 35-d mice has only a few percent of the thymorytes present in the control thymus. The thymus at day 21 lacks small lymphocytes in the cortex, and the distinction between cortex and medulla becomes ambiguous. Third, uniformly large blast-like cells with high mi- 353 Obata et al .
totic activity repopulate and occupy the thymus of 35-d or older mice. With increase in this cell population, both thymus weight and cell number show partial recovery. Abnormal Thymic T Cell Differentiation. As shown in Fig.  3 , the antigenic profile of thymocytes of TgTla'-3-1 mice also undergoes drastic changes, in parallel with the growth of the thymus described above. The thymus at each age (before day 14, at day 21 and after day 35) shows a distinct and abnormal representation of the four T cell subpopulations belonging to the different maturation stages, the least mature L3T4 -Lyt-2' DN, the immature L3T4+Lyt-2' double positive (DP) and the mature L3T4+Lyt-2-or L3T4 -Lyt-2+ single positive (SP) cells. Thy-1 expression by the thymic cell population indicates their T cell origin . Until day 14, the thymus has a T cell profile similar to the control, but it contains an expanded population of DN cells and a relatively small population of DP cells . The sudden disappearance of cells from the transgenic thymus between day 14 and day 21 involves 90% of DP thymocytes as well as 85% of DN thymocytes. As a result, the thymus of day 21 mice has all four subpopulations in equal proportion . At day 35, DN cells become the major population, with 90% of thymocytes being DN and the remaining 10% Lyt-2+ SP cells, while DP and L3T4+ SP cells become undetectable. This abnormal phenotype becomes stable after day 35, indicating that the differentiation pathway from DN to DP thymocytes has been lost, while the DN pathway remains active. As calculated from Fig. 1 and 3 , the number of DP cells in transgenic thymus is <105 after day 35, while the control thymus contains 1 .5 x 108 DP cells at day 35 and 9 x 10 7 at day 70. In contrast, the number of DN thymocytes increases after day 21 and the thymus at day 70 contains 8 x 10 6 DN thymocytes, twice as many as the age-matched control .
Studies of TCR expression show that DN cells in day 70 thymus express TCR yb (Fig. 3, Row 4) . However, this commitment of DN cells to TCR yb becomes evident only at day 35, as the majority of DN cells are negative for TCR -yb expression before day 21 . The differentiation pathway to TCR aR+ SP cells is disturbed in the transgenic thymus (Fig. 3, Row 3) , since there are very few TCR a#+L3T4+ SP cells in 35-d or older mice. TCR cxd expression is detected on the relatively expanded SP thymocytes in day 21 mice and on Lyt-2+ SP thymorytes in older mice. TCR cx6 and yb expression is always accompanied by CD3 expression (Fig. 3, Row 5 ), suggesting that both TCR a(3 and yb on the cell surface are functional .
A variable proportion of the DN thymorytes of young transgenic mice expresses I1r2 receptor ot chain (IIr2Ra), HSA, and Pgp-1 . For example, of the DN thymocytes of day 21 mice, 69% are IL2Ra+, 30% HSA+ and 16% Pgp-1+ . The DN cells of the control thymus are consistently heterogeneous in terms of the expression of these antigens. However, TCR yb+ DN thymocytes of 70-d-old transgenic mice become homogeneously negative for these antigens (data not shown) . The antigenic profile of T cells in peripheral nodes also undergoes changes characteristic of TgTlaa-3-1 mice (data not shown) . At day 21, the T cell population in the lymph nodes of transgenic mice is similar to that in control mice except the expression of TL; 95% of T cells are TCR czO+ Expression of the Transgene in TgX1aQ-3-1 Thymus. TL antigen, the product of the Tlaa-3 transgene, is expressed in Tg.Tlaa-3-1 thymus in a much larger quantity (about 10 times) than in the thymus of any inbred TL+ strain, including the A-strain from which the transgene was isolated (see reference 8) . Further, TL antigen is detected in almost all thymic T cells of Tg.Tlaa-3-1, including DN and SP cells, although a fraction of DN cells in younger mice is TL - (Fig . 3, Row 2) . The proportion of TL+ DP cells decreases with aging, while TL+ DN cells increase and become the major population of the thymus. In B6Tlaa, only DP thymocytes express TL antigens, while DN and SP thymocytes are TL -. TL antigen is expressed in almost all T cells in the lymph nodes of transgenic mice, including TCR yS+ DN and TCR aa+ SP cells . This contrasts with the situation in other TL+ mouse strains, where peripheral T cells do not express TL antigen .
T Cell Abnormality Resides in Bone Marrow Stem Cells. To determine whether stem cells derived from the bone marrow or the thymic environment of TgTlaa-3-1 are responsible for the abnormal differentiation of T cells, bone marrow transplantation and thymus grafting were carried out. The thymus of AKR mice (Thy-1.1+TL -) reconstituted with bone marrow cells of transgenic mice showed the characteristics of the transgenic thymus ; the majority of thymocytes were large blast-like cells and the cortex-medulla distinction was unclear (data not shown) . The thymocytes of chimeric mice were entirely replaced by Thy-1.2+ TL+ cells of donor origin, and the major population was TCR yS+ DN cells (Fig. 4) . Results from the reciprocal combination could not be obtained, because TgTlaa-3-1 recipients of AKR bone marrow cells did not survive. However, chimeric TgTlaa-3-1 mice receiving OH/He bone marrow were produced and were found to have normal thymic morphology and a normal population of thymic T cells (data not shown) . These results indicate that bone marrow stem cells rather than the thymic environment (including thymic epithelial cells) cause the abnormal thymic differentiation of TgTlaa-3-1 mice . This conclusion is confirmed by experiments involving reciprocal thymic graft . OH/He thymus transplanted under the capsule of Tg.Tlaa-3-1 kidney takes on the characteristics of the transgenic thymus. 5 wk after the grafting, the thymus becomes smaller with no clear cortex-medulla distinction and is constituted mainly of large lymphoid cells with a TL+TCR yb+ DN phenotype. In contrast, TgTlaa-3-1 thymus transplanted into C3H/He mice show normal T cell population and morphology (data not shown) .
Deficient T Cell Immune Function in Tg.Tlaa-3-1 Mice. TgXlaa-3-1 mice of day 70 or older were examined for their immune capacity in four different assays. In PFC assays in the response to SRBC, Tg.Tlaa-3-1 mice yielded fewer IgM- and IgGproducing cells than the control, as shown in Fig. 5 A .
In vitro proliferative responses in MLC against allogenic BALB/c and B6 spleen cells showed that the transgenic mice were less reactive than the control (Fig. 5 B) . Similarly, in the mitogenic response to Con A, transgenic spleen cells were less efficiently stimulated (Fig. 5 C) . As the spleens of transgenic mice contain one half the T cells present in control spleens (see above), the same number of T cells isolated from Tg.Tlaa-3-1 and C3H/He spleens were compared in their response to Con A. The results indicate that the T cells of transgenic mice are less reactive than those of the control . In contrast to these T cell dependent assays, the proliferative response of transgenic spleen cells to LPS was normal (data not shown) . These results indicate that T cell function of TgTla'-3-1 mice is impaired, whereas B cell function is not . Development of T Cell Lymphomas in Tg.Tlaa-3-1. TgTla'-3-1 mice of 8-15 mo-old often developed enlargement of spleen and lymph nodes . Liver, lung and kidney were frequently involved, while overt enlargement of the thymus was rare. The infiltrating cells were larger than normal lymphocytes, with more vesicular nuclei and with relatively abundant cytoplasm . The gross and microscopic characteristics were similar in all cases, and these neoplasms could be classified as "lymphocytic leukemia" according to Dunn (38) . The incidence was over 60%D (32/51 mice) and the tumors were transplantable in C3H/He mice. C3H/He, used for the derivation of the transgenic strain, has a low incidence of lymphocytic leukemia (39) . 357 Obata et al. . Surface antigenic profile of TgTla'-3-1 lymphocytic leukemias . Two-color analysis of cell surface antigens of tumor cells was carried out as described in the legend to Fig. 3 . The results with three tumors are illustrated in this figure. All three are Thy-1+TL+Lyt-2 -L3T4 -; two (C2 and D20) are TCR y6*CD3', while one (El) is TCR -CD3 -. Most other lymphomas are similar to C2 and D20 (see Table 1 ) .
The cell surface phenotype of these lymphoma cells was examined (Fig. 6 and Table 1 ) . Cells from 21 lymphomas were Thy-1+TL+L3T4 -Lyt-2 -TCR a(3 -. Most cells expressed TCR -y6 and CD3, while a few were negative for TCR y6 and CD3 . The expression of IIr2Ra and HSA was generally not detected. The tumors were heterogeneous with regard to the expression of Pgp-1.
The structure and expression of TCR genes were also examined and the results are summarized in Table 1 . All except one lymphoma (A8) had rearranged TCR y and 6 genes and transcribed y and 6 mRNA of the functional sizes : A8 had germline TCR y genes and no y transcripts of the functional size. No tumor expressed both TCR a and /3 functional tran- scripts simultaneously, although some expressed either TCR a or 0 transcripts of functional sizes. These results correlate well with the results of flow cytometry as described above, although a discrepancy was found with one tumor (El), which expressed functional y and S mRNA, but was negative for TCR yb expression . These results of molecular and serological analyses indicate that the majority of "lymphocytec leukemias" of Tg.Tla'-3-1 mice originate from DN cells belonging to the TCR yb lineage, with a few lymphomas arising from the DN cells before lineage commitment.
Discussion
The present study of a TL transgenic mouse strain characterized by high levels of TL antigen expression in thymocytes and abnormal thymic development, reveals that thymic 358 yS T Cells in TL Transgenic Mice T cell differentiation in this strain is deviated almost exclusively toward the yb lineage . Bone marrow transplantation and thymic graft experiments clearly demonstrate that the abnormality resides in the stem cells of bone marrow and not in the thymic environment including the thymic epithelial cells . The most striking event is a sudden disappearance of small lymphocytes from the thymus between day 14 and day 21 . This event is distinct from the disappearance of thymocytes induced by stress, irradiation or administration of cortisone. The thymus of TgTla'-3-1 mice shows neither a "moth-eaten" structure nor the accumulation of macrophages, eosinophils or necrotic cells in the cortex, which are associated with the disappearance of thymocytes by these other causes (40) . The loss ofthymocytes in transgenic mice between day 14 and day 21 is dependent on the genetic background, since a similar phenomenon occurs but much delayed in (C3H/ 
He x TgTlaa-3-1), (B6 x TgTlaa-3-1) and (B6Tlaa x TgTlaa-3-1) Ft mice. The presence of Lyt-2+ SP cells in older thymus seems not to be essential for the event, because no Lyt-2+ SP cells are present in the thymus of the bone marrow chimera mice as shown in Fig. 4 . The gradual increase of large blast-like yb DN thymocytes in older mice is an another feature of the transgenic thymus . After day 21, DN thymocytes become the major population and their differentiation appears to be restricted to yb DN cells. Two possible mechanisms may account for the disappearance of thymocytes and proliferation of yb DN thymocytes. One possibility involves a defect in proliferation and differentiating capacity of stem cells involved in the development of T cells, with an abnormal deviation toward the yb lineage . The other possibility is the rapid removal of cells belonging to the ctf lineage including all DP and some DN cells, while leaving those in the yb lineage intact. Although no visible cell death was observed in day 14 or day 21 thymus, further study of this possibility is required, e .g., molecular analysis to detect DNA fragmentation, a sign of apoptosis, in vitro organ culture of the thymus, and determination of TCR repertoires of the yb DN thymocytes . The embryonic thymus of transgenic mice is not grossly abnormal, and the growth of the thymus after birth is close to normal until day 14 . However, an event occurring during embryonic life may trigger the abnormal T cell differentiation, and a detailed analysis of thymic development during embryogenesis is now under way.
What is the role of the transgene in these abnormal events, and what is the function of TL in normal differentiation? It is certain that TL expression in the thymus of the transgenic mice is not a cause of these events, since conventional TL' strains and the other transgenic strain, TgTlaa-3-2, do not show the abnormality. We can not exclude the possibility that the abnormality is a result of insertional activation or mutagenesis of genes unrelated to TL. However, this genetic alteration has to be under the control of the inserted TL transgene, since the abnormal phenotype is inherited as a dominant trait and is restricted to tissues that express the transgene. These requirements make unrelated insertional mechanisms unlikely. However, to eliminate this possibility, over 20 new transgenic mice with various TL and TL chimeric genes have been derived and are now being established. The possibility we feel best explains the results obtained thus far is that quantitative or qualitative abnormalities in TL expression in the transgenic mice above a certain threshold cause abnormal T cell differentiation in the transgenic mice . The facts are that (a) these mice express over 10 times the level of TL antigen found in conventional TL' or TgTlaa-3-2 mice, (b) TL is expressed on DN thymocytes which are negative in conventional TL+ mice, and (c) the abnormality is restricted to tissues that express TL. Fl mice of (C3H/He x TgTlaa-3-1), (B6 x TgTlaa-3-1) and (136Th' x TgTlaa-3-1) crosses show the characteristic abnormalities of Tg.Tla°-3-1 mice, but the onset of the abnormalities is delayed and not so pronounced as in parental homozygous TgTlaa-3-1 mice (data not shown) . These results indicate dominant inheritance of the abnormality with a gene dosage effect, suggesting that an amplified level of TL expression is causally 359 Obata et al .
related to abnormal thymic differentiation . If this assumption is correct, one can assume that TL plays "a critical role in T cell development in the thymus and that thymocytes of TL -mice must express other MHC class I antigens that are functional equivalents to TL . It has been reported that some MHC class I genes mapping to the Tla region function as ligands for yb TCRs (15, 16, 41, 42) . However, unlike TL genes, these other class I genes are expressed in a variety of tissues. Recently, the expression of TL in intestinal epithelium has been described and its relation to yb cells has been discussed (43, 44) . It remains to be seen whether TL serves as ligands for certain yb TCRs, whether TL is involved in the selection process of yb cells, and whether altered expression of TL disturbs the normal differentiation of yb cells. Much effort has been made to characterize yb cells and a vast amount of information has been accumulated (15-18) . However, analysis of yb cells in the peripheral lymphoid organs has been difficult because of their minor representation (20) (21) (22) . With the advantage of the relative abundance of yb cells and -yb T cell lymphomas in TgTlaa-3-1, we have attempted to stage the maturation of yb cells. From analysis of surface antigens, the following pathway for yb DN cells is proposed : the least mature stage 1, IIr2Rac+HSA+Pgp-1+TCR -; stage 2, IIr2RocHSA+Pgp-1+TCR -; stage 3, ID2Ra-HSA -Pgp-1+TCR yb+ ; and the most mature stage 4, 11, 2RorHSA -Pgp-1 -TCR yb+ . The appearance of surface TCR yb accompanying CD3 expression occurs between stage 2 and 3 . This proposed pathway is obviously not complete and may not be applicable to all subsets of yb cells, but this sequence of changes in the surface phenotype is similar to that proposed for TCR a(3 lineage (13, 14) . Determination of the V region usage (45) in the yb thymocytes and T cell lymphomas should reveal which subsets of yb cells belong to this pathway. Immunization using DN cells and T cell lymphomas from TgTlaa-3-1 mice may produce reagents specific to the yb lineage and may identify counterparts of Lyt-2 and L3T4 on yb DN cells .
The immune response of TgTlaa-3-1 mice is severely impaired, with T cells being inefficient in helper function for antibody production, in allogeneic MLC and in Con A stimulation. Since nearly one half of the peripheral T cells in mature TgTlaa-3-1 mice are yb DN cells, the results strongly suggest that yb cells cannot participate in or are less active in these T cell dependent reactions. Further, the results indicate that the function of cxl cells in these transgenic mice is also affected, suggesting that only incompetent ao cells are produced because of the abnormal thymic development . Alternatively, it is conceivable that the function of as cells is suppressed by yb cells in these transgenic mice. The function of yb cells is largely unknown and their reactivity to allo-antigens or to mitogens is still unclear. Accordingly, the use of isolated population of yb cells from TgTlaa-3-1 mice in the analysis of other immune functions such as reactivity to mycobacterial antigens and generation of lymphokines, should help in dissecting the functions of yb cells and their relation to the functions of cto cells .
Development of yb T cell lymphomas is another important feature of TgTlaa-3-1 mice. A relatively long latent period and clonality of these lymphomas clearly indicates that tumor development requires other genetic events in addition to the transgene, in a manner similar to lymphomagenesis in c-mw transgenic mice (46, 47) . Why are Tg.Tla'-3-1 mice susceptible to lymphomas and why do all lymphomas originate from the yS lineage? An obvious reason for the yS phenotype is that the preponderance of thymocytes in older transgenic mice are yS cells, while aO cells are a minor population .
There is no evidence to indicate that -yb cells are more susceptible to lymphomagenesis than cig cells, as there have been only a few reports on yS T cell lymphomas in mice or in human (48, 49) . A higher mitotic rate of thymocytes in transReferences genic mice than in nontransgenic mice indicates that transgenic thymocytes are rapidly dividing, suggesting that one of the events necessary for the ultimate development of lymphomas may have already occurred in these cells. To understand the genetic basis for the sensitivity of yb cells to lymphomagenesis and how this relates to abnormal T cell differentiation, crosses between TgTla'-3-1 mice and high or low lymphoma strains have been made. These mice should provide useful information on the role of TL in the development of the yS T cell lymphomas and also advance our understanding of the significance of TL expression in radiationinduced lymphoma and prelymphoma cells (50) (51) (52) .
